By pharmacological approaches, we further showed that a distinct G s /cAMP-protein kinase A (PKA)/inositol 1,4,5-trisphosphate (IP 3 )/Ca 2+ /calmodulin (CaM)/CaM-dependent protein kinase II (CaMKII) signaling pathway is responsible for the exendin-4 effect on GCs
Very low Mechanism-based claims without meaningful human outcome data
Some GLP-1 agonists, like Zepbound, Wegovy, and Saxenda (liraglutide), are FDA approved for chronic weight management
Because it works partly like GLP-1 medicines, researchers want to know if it may help with metabolic and heart-related conditions
Just be patient, and stick to your efforts
Below is the complete reference table: Source: FDA prescribing information